Chemaxon newsroom

Christa E. Müller

12 09 2019
< 1 minute

A2B Adenosine Receptor Antagonists with Picomolar Potency

The A2B adenosine receptor (A2BAR) was proposed as a novel target for the (immuno)therapy of cancer...